» Articles » PMID: 23690477

HLA Class I Antibodies Trigger Increased Adherence of Monocytes to Endothelial Cells by Eliciting an Increase in Endothelial P-selectin And, Depending on Subclass, by Engaging FcγRs

Overview
Journal J Immunol
Date 2013 May 22
PMID 23690477
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Ab-mediated rejection (AMR) of solid organ transplants is characterized by intragraft macrophages. It is incompletely understood how donor-specific Ab binding to graft endothelium promotes monocyte adhesion, and what, if any, contribution is made by the Fc region of the Ab. We investigated the mechanisms underlying monocyte recruitment by HLA class I (HLA I) Ab-activated endothelium. We used a panel of murine mAbs of different subclasses to crosslink HLA I on human aortic, venous, and microvascular endothelial cells and measured the binding of human monocytic cell lines and peripheral blood monocytes. Both anti-HLA I murine (m)IgG1 and mIgG2a induced endothelial P-selectin, which was required for monocyte adhesion to endothelium irrespective of subclass. mIgG2a but not mIgG1 could bind human FcγRs. Accordingly, HLA I mIgG2a but not mIgG1 treatment of endothelial cells significantly augmented recruitment, predominantly through FcγRI, and, to a lesser extent, FcγRIIa. Moreover, HLA I mIgG2a promoted firm adhesion of monocytes to ICAM-1 through Mac-1, which may explain the prominence of monocytes during AMR. We confirmed these observations using human HLA allele-specific mAbs and IgG purified from transplant patient sera. HLA I Abs universally elicit endothelial exocytosis leading to monocyte adherence, implying that P-selectin is a putative therapeutic target to prevent macrophage infiltration during AMR. Importantly, the subclass of donor-specific Ab may influence its pathogenesis. These results imply that human IgG1 and human IgG3 should have a greater capacity to trigger monocyte infiltration into the graft than IgG2 or IgG4 due to enhancement by FcγR interactions.

Citing Articles

Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms.

Bery A, Belousova N, Hachem R, Roux A, Kreisel D Transplantation. 2024; 109(3):454-466.

PMID: 39104003 PMC: 11799353. DOI: 10.1097/TP.0000000000005162.


New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation.

Franco-Acevedo A, Comes J, Mack J, Valenzuela N Front Transplant. 2024; 2:1146040.

PMID: 38993843 PMC: 11235244. DOI: 10.3389/frtra.2023.1146040.


Targeting Macrophages in Organ Transplantation: A Step Toward Personalized Medicine.

Owen M, Kopecky B Transplantation. 2024; 108(10):2045-2056.

PMID: 38467591 PMC: 11390981. DOI: 10.1097/TP.0000000000004978.


Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy.

Nevarez-Mejia J, Jin Y, Pickering H, Parmar R, Valenzuela N, Sosa R Am J Transplant. 2024; 24(3):406-418.

PMID: 38379280 PMC: 11110958. DOI: 10.1016/j.ajt.2023.10.020.


Spatial multiomics of arterial regions from cardiac allograft vasculopathy rejected grafts reveal novel insights into the pathogenesis of chronic antibody-mediated rejection.

Nevarez-Mejia J, Pickering H, Sosa R, Valenzuela N, Fishbein G, Baldwin 3rd W Am J Transplant. 2024; 24(7):1146-1160.

PMID: 38219867 PMC: 11239797. DOI: 10.1016/j.ajt.2024.01.004.


References
1.
Endeman H, Cornips M, Grutters J, van den Bosch J, Ruven H, van Velzen-Blad H . The Fcgamma receptor IIA-R/R131 genotype is associated with severe sepsis in community-acquired pneumonia. Clin Vaccine Immunol. 2009; 16(7):1087-90. PMC: 2708405. DOI: 10.1128/CVI.00037-09. View

2.
Bian H, Harris P, Reed E . Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation. Int Immunol. 1998; 10(9):1315-23. DOI: 10.1093/intimm/10.9.1315. View

3.
Warmerdam P, van de Winkel J, Gosselin E, Capel P . Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). J Exp Med. 1990; 172(1):19-25. PMC: 2188138. DOI: 10.1084/jem.172.1.19. View

4.
Fleck R, Athwal H, Bygraves J, Hockley D, Feavers I, Stacey G . Optimization of nb-4 and hl-60 differentiation for use in opsonophagocytosis assays. In Vitro Cell Dev Biol Anim. 2003; 39(5-6):235-42. DOI: 10.1290/1543-706X(2003)039<0235:OONAHD>2.0.CO;2. View

5.
Gosselin E, Brown M, Anderson C, Zipf T, Guyre P . The monoclonal antibody 41H16 detects the Leu 4 responder form of human Fc gamma RII. J Immunol. 1990; 144(5):1817-22. View